Bahl & Gaynor’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-652
| Closed | -$206K | – | 329 |
|
|
2020
Q1 | $206K | Buy |
+652
| New | +$206K | ﹤0.01% | 320 |
|
|
2019
Q1 | – | Sell |
-893
| Closed | -$269K | – | 347 |
|
|
2018
Q4 | $269K | Sell |
893
-32
| -3% | -$9.64K | ﹤0.01% | 318 |
|
|
2018
Q3 | $327K | Sell |
925
-71
| -7% | -$25.1K | ﹤0.01% | 332 |
|
|
2018
Q2 | $289K | Buy |
996
+53
| +6% | +$15.4K | ﹤0.01% | 341 |
|
|
2018
Q1 | $258K | Buy |
943
+18
| +2% | +$4.93K | ﹤0.01% | 374 |
|
|
2017
Q4 | $295K | Sell |
925
-32
| -3% | -$10.2K | ﹤0.01% | 372 |
|
|
2017
Q3 | $300K | Sell |
957
-171
| -15% | -$53.6K | ﹤0.01% | 363 |
|
|
2017
Q2 | $306K | Buy |
+1,128
| New | +$306K | ﹤0.01% | 374 |
|
|
2016
Q4 | – | Sell |
-645
| Closed | -$202K | – | 387 |
|
|
2016
Q3 | $202K | Buy |
+645
| New | +$202K | ﹤0.01% | 382 |
|
|
2016
Q1 | – | Sell |
-692
| Closed | -$212K | – | 409 |
|
|
2015
Q4 | $212K | Buy |
+692
| New | +$212K | ﹤0.01% | 411 |
|
|
2015
Q3 | – | Sell |
-642
| Closed | -$259K | – | 434 |
|
|
2015
Q2 | $259K | Sell |
642
-77
| -11% | -$31.1K | ﹤0.01% | 406 |
|
|
2015
Q1 | $304K | Buy |
+719
| New | +$304K | ﹤0.01% | 376 |
|